Limitations of Stem Cell Therapy for Parkinson’s Disease
Cells · 03.05.2026 · 15 (9) · 839
DOI: 10.3390/cells15090839 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.05.2026. Verfasst von Zhuowei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Peking University First School of Clinical Medicine, Peking University Health Science Center, Beijing 100191, China. Hauptthemen laut MEDLINE: Parkinson Disease, Stem Cell Transplantation, Cell- and Tissue-Based Therapy, Stem Cells. Die Arbeit nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Stem cell therapy, as a potential treatment for Parkinson’s disease (PD), has been investigated in many clinical trials for its effectiveness. However, the therapeutic outcomes have shown considerable variability. This may be due to certain limitations of stem cell therapies, such as the inability to ameliorate non-motor symptoms or modify underlying disease mechanisms, and the limited applicability in certain patient populations. Combinations with the recently emerging gene therapy and other available technologies are expected to make up for or break down these limitations of stem cell therapy, thereby broadening its scope of application. In this review, we will discuss the limitations of stem cell therapy in terms of pathogenesis, symptoms, and population, as well as possible coping strategies to enhance the effectiveness of stem cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Peking University First School of Clinical Medicine, Peking University Health Science Center, Beijing 100191, China.
- Department of Neurosurgery, Peking University People's Hospital, Beijing 100044, China.
ORCID-Profile: Jia Ouyang
Förderung
- the National Key Research and Development Program of China
- the National Natural Science Foundation of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Peng, S., Ouyang, J., & Liu, R. (2026). Limitations of Stem Cell Therapy for Parkinson’s Disease. Cells, 15(9), 839. https://doi.org/10.3390/cells15090839
Vancouver
Li Z, Peng S, Ouyang J, Liu R. Limitations of Stem Cell Therapy for Parkinson’s Disease. Cells. 2026;15(9):839. doi:10.3390/cells15090839
BibTeX
@article{Li2026,
author = {Li, Zhuowei and Peng, Shijun and Ouyang, Jia and Liu, Ruen},
title = {Limitations of Stem Cell Therapy for Parkinson’s Disease},
journal = {Cells},
year = {2026},
volume = {15},
number = {9},
pages = {839},
doi = {10.3390/cells15090839}
}
EUVIMED